CNBC Investing Club Reveals Top and Bottom Performers During SixWeek Market Rally New York Fed Study Reveals LowerIncome Households Feel the Pinch from Rising Gas Prices BristolMyers Squibb Draws Hedge Fund Interest with 425 Dividend Yield and AI Partnership General Compute Launches First ASICNative Neocloud for Agent Applications Ferrari Lear Intuitive Machines Micron Lead Premarket Movers WSJs Heard on the Street Launches Eighth Annual StockPicking Contest RPM Q1 2026 Earnings Strong EPS Beat Driven by Margin Expansion and Operational Efficiency SLSN Q1 2026 Earnings Narrow Loss Reported Amid Quiet Quarter RMCF Q1 2026 Earnings Loss per Share Narrows as Stock Gains 415 DTW Q1 2026 Earnings EPS Misses Estimates as Debenture Price Slips KNTK Q1 2026 Earnings EPS Falls Sharply Short of Estimates Amid Disappointing Quarter Guidewire Software GWRE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Sentiment EnerSys ENS Rallies 481 in Strong Session Approaching Key Resistance Lafayette Digital Acquisition Corp I Warrants ZKPW Remain Flat Near Support as Investors Weigh SPAC Dynamics Strattec Security STRT Edges Higher in Quiet Trading Holding Above Key Support Extreme Networks EXTR Surges 7 on Strong Volume Approaches Resistance at 2688 WEBUY GLOBAL LTD WBUY Pulls Back to 103 Key Support in Focus After 19 Decline Polymarket Traders Hint SpaceX OpenAI and Anthropic Could Surpass 14 Trillion on Trading Debut URBN Q1 2026 Earnings EPS Surges Past Estimates but Stock Dips Slightly Enovis Corporation ENOV Holds Near Support Amid Modest Decline First Hawaiian Inc FHB Edges Higher Amid Consolidation Support and Resistance Levels in Focus Western Alliance Bancorp WAL Rises 126 as Regional Bank Sector Gains Traction SoFi Technologies SOFI Edges Higher Analyzing the Recent Uptick McDonalds MCD Slips Slightly Amid Consolidation Key Support and Resistance Levels in Focus Somnigroup International SGI Edges Lower Amid Quiet Trading Key Levels in Focus Six Flags Entertainment FUN Edges Higher as Stock Nears Key Resistance Zone Polaryx Therapeutics PLYX Slips 271 as Stock Tests Key Support Near 238